LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+5.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+5.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$17.50M-
2024$0.00-
2023$0.00-100.0%
2022$15.00M-
2021$0.00-
2020$0.00-
2019$0.00-